Agilon Health (AGL)
Enables primary-care groups to run Medicare-focused risk-bearing care models.
$85.35
vs last close−1.49 (−1.72%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,137 | 816 | 1,604 | 1,483 | 1,451 | 1,522 | 1,533 | 1,395 | 1,435 | 1,569 | 1,420 | 1,495 |
| Cost of revenue | 1,100 | 911 | 1,529 | 1,451 | 1,515 | 1,561 | 1,482 | 1,447 | 1,503 | 1,667 | 1,362 | 1,388 |
| Gross profit | 37 | −95 | 75 | 32 | −64 | −38 | 51 | −52 | −68 | −98 | 58 | 107 |
| 76 | 64 | 82 | 76 | 69 | 70 | 73 | 64 | 64 | 58 | 48 | 95 | |
| 72 | 63 | 76 | 70 | 63 | 60 | 66 | 56 | 56 | 60 | 54 | 89 | |
| General & administrative | 72 | 63 | 76 | 70 | 63 | 60 | 66 | 56 | 56 | 60 | 54 | 89 |
| Other expenses | 4 | 1 | 6 | 6 | 6 | 10 | 7 | 7 | 7 | −2 | −6 | 7 |
| Operating income | −39 | −160 | −7 | −43 | −134 | −108 | −22 | −116 | −131 | −156 | 10 | 12 |
| 18 | −3 | 10 | 13 | 16 | 3 | 20 | 12 | 21 | −32 | 20 | 6 | |
| Interest expense | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | −2 | 2 |
| Other non-operating income | −20 | 1 | −12 | −15 | −18 | −5 | −22 | −13 | −23 | 30 | −18 | 7 |
| Income before tax | −21 | −163 | 3 | −30 | −117 | −105 | −2 | −104 | −111 | −188 | 30 | 18 |
| Income tax expense | 1 | 0 | 0 | 0 | −1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net income from continuing operations | −22 | −163 | 3 | −31 | −116 | −106 | −2 | −104 | −110 | −189 | 30 | 18 |
| Discontinued operations | −9 | −68 | −9 | 0 | −1 | 1 | 14 | 0 | 0 | 0 | 0 | 0 |
| Net income | −31 | −230 | −6 | −31 | −118 | −106 | 12 | −104 | −110 | −189 | 30 | 18 |
| EPS, basic | −$2.00 | −$14.00 | −$0.37 | −$1.87 | −$7.25 | −$6.50 | $0.75 | −$6.25 | −$6.75 | −$11.50 | $1.80 | $1.07 |
| EPS, diluted | −$2.00 | −$14.00 | −$0.37 | −$1.87 | −$7.25 | −$6.50 | $0.75 | −$6.25 | −$6.75 | −$11.50 | $1.80 | $1.04 |
| Weighted average shares, basic | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 | 17 | 17 | 17 | 17 |
| Weighted average shares, diluted | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 | 17 | 17 | 17 | 17 |
| EBITDA | −14 | −156 | 10 | −23 | −109 | −97 | 7 | −95 | −101 | −179 | 35 | 11 |
| Depreciation & amortization | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 |
| EBIT | −19 | −161 | 4 | −29 | −115 | −103 | 0 | −103 | −109 | −186 | 28 | 4 |
